[SCHEDULE 13G] Halliburton Company SEC Filing
Capital Research Global Investors (CRGI) reports beneficial ownership of 50,061,312 shares of Halliburton common stock, representing 5.8% of the shares believed to be outstanding. CRGI states it has sole voting power over 50,061,245 shares and sole dispositive power over 50,061,312 shares. The filing identifies CRGI as an investment management division of Capital Research and Management Company and affiliated entities that provide investment services under the name Capital Research Global Investors. The statement affirms these shares were acquired and are held in the ordinary course of business and were not acquired to change or influence control of the issuer.
Capital Research Global Investors (CRGI) dichiara la propriet脿 effettiva di 50.061.312 azioni ordinarie di Halliburton, pari al 5,8% delle azioni ritenute in circolazione. CRGI afferma di avere la potest脿 di voto esclusiva su 50.061.245 azioni e la disponibilit脿 esclusiva su 50.061.312 azioni. La comunicazione identifica CRGI come una divisione di gestione degli investimenti di Capital Research and Management Company e da entit脿 affiliate che forniscono servizi di investimento con il nome Capital Research Global Investors. La dichiarazione conferma che queste azioni sono state acquisite e sono detenute nell'ordinaria attivit脿 commerciale e non sono state acquistate per modificare o influenzare il controllo dell'emittente.
Capital Research Global Investors (CRGI) informa la titularidad beneficiaria de 50.061.312 acciones ordinarias de Halliburton, que representan el 5,8% de las acciones que se estima est谩n en circulaci贸n. CRGI declara tener poder de voto exclusivo sobre 50.061.245 acciones y poder exclusivo de disposici贸n sobre 50.061.312 acciones. La presentaci贸n identifica a CRGI como una divisi贸n de gesti贸n de inversiones de Capital Research and Management Company y entidades afiliadas que prestan servicios de inversi贸n bajo el nombre Capital Research Global Investors. La declaraci贸n afirma que estas acciones fueron adquiridas y se mantienen en el curso ordinario del negocio y no fueron compradas para cambiar o influir en el control del emisor.
Capital Research Global Investors (CRGI)電� Halliburton 氤错喌欤� 50,061,312欤检棎 雽�頃� 鞁れ鞝� 靻岇湢甓岇潉 氤挫湢頃橁碃 鞛堨溂氅�, 鞚措姅 氚滍枆欤检嫕鞙茧 於旍爼霅橂姅 欤检嫕鞚� 5.8%鞐� 頃措嫻頃滊嫟瓿� 氤搓碃頃╇媹雼�. CRGI電� 50,061,245欤检棎 雽�頃� 雼弲 鞚橁舶甓�鞚�, 50,061,312欤检棎 雽�頃� 雼弲 觳橂秳甓�鞚� 氤挫湢頃橁碃 鞛堧嫟瓿� 氚濏灆雼堧嫟. 鞝滌稖 靹滊電� CRGI毳� Capital Research and Management Company鞚� 韴瀽鞖挫毄 攵�氍� 氚� Capital Research Global Investors霛茧姅 氇呾弓鞙茧 韴瀽 靹滊箘鞀るゼ 鞝滉车頃橂姅 瓿勳棿靷摛搿� 鞁濍硠頃╇媹雼�. 鞚� 歆勳垹鞚� 頃措嫻 欤检嫕霌れ澊 韱奠儊鞝侅澑 鞓侅梾 瓿检爼鞐愳劀 旆摑霅橃柎 氤挫湢霅橁碃 鞛堨溂氅� 氚滍枆鞚胳潣 歆�氚瓣秾 氤�瓴届澊雮� 鞓來枼霠レ潉 頄夓偓頃橁赴 鞙勴暣 旆摑霅� 瓴冹澊 鞎勲嫎鞚� 頇曥澑頃╇媹雼�.
Capital Research Global Investors (CRGI) d茅clare d茅tenir la propri茅t茅 b茅n茅ficiaire de 50 061 312 actions ordinaires de Halliburton, repr茅sentant 5,8% des actions estim茅es en circulation. CRGI indique disposer du pouvoir de vote exclusif sur 50 061 245 actions et du pouvoir exclusif de disposition sur 50 061 312 actions. Le d茅p么t identifie CRGI comme une division de gestion d'investissements de Capital Research and Management Company et des entit茅s affili茅es fournissant des services d'investissement sous le nom Capital Research Global Investors. La d茅claration confirme que ces actions ont 茅t茅 acquises et sont d茅tenues dans le cours normal des affaires et n'ont pas 茅t茅 acquises dans le but de modifier ou d'influencer le contr么le de l'茅metteur.
Capital Research Global Investors (CRGI) meldet wirtschaftliches Eigentum an 50.061.312 Stammaktien von Halliburton, was 5,8% der angenommenen ausstehenden Aktien entspricht. CRGI gibt an, 眉ber 50.061.245 Aktien die ausschlie脽liche Stimmrechtsbefugnis und 眉ber 50.061.312 Aktien die ausschlie脽liche Verf眉gungsbefugnis zu haben. Die Meldung bezeichnet CRGI als Investment-Management-Division von Capital Research and Management Company sowie verbundene Unternehmen, die Anlageleistungen unter dem Namen Capital Research Global Investors erbringen. Die Erkl盲rung best盲tigt, dass diese Aktien im normalen Gesch盲ftsverlauf erworben und gehalten wurden und nicht zum Zweck des Erwerbs oder der Beeinflussung der Kontrolle des Emittenten erworben wurden.
- Beneficial ownership disclosed: 50,061,312 shares, representing 5.8% of outstanding common stock.
- Sole voting and dispositive power: CRGI reports sole voting power over 50,061,245 shares and sole dispositive power over 50,061,312 shares.
- Passive intent declared: Filing certifies holdings are in the ordinary course of business and not for changing or influencing control.
- Institutional filer: CRGI is identified as an investment adviser and a division of Capital Research and Management Company with affiliated entities.
- None.
Insights
TL;DR: Institutional investor holds a material 5.8% stake but reports passive intent; voting and dispositive power largely aligned with holdings.
CRGI discloses ownership of 50,061,312 shares (5.8%), crossing the 5% Schedule 13G threshold that requires public reporting. Reported sole voting power of 50,061,245 and sole dispositive power of 50,061,312 indicate operational control of the economic interests in the position. The filing classifies CRGI as an investment adviser and explicitly states the position is held in the ordinary course of business and not to influence control, consistent with a passive institutional holding.
TL;DR: Disclosure shows a significant passive stake with near-complete sole voting/dispositive authority, signalling institutional influence without active control intent.
The schedule identifies CRGI as a division of Capital Research and Management Company and affiliated investment entities, collectively reporting the stake. While the holder reports sole voting and dispositive powers over virtually all reported shares, the certification in the filing that the shares are not held to change or influence control is material for governance considerations. This positions CRGI as a sizable, passive shareholder whose voting capacity could be relevant in governance matters despite no declared control intent.
Capital Research Global Investors (CRGI) dichiara la propriet脿 effettiva di 50.061.312 azioni ordinarie di Halliburton, pari al 5,8% delle azioni ritenute in circolazione. CRGI afferma di avere la potest脿 di voto esclusiva su 50.061.245 azioni e la disponibilit脿 esclusiva su 50.061.312 azioni. La comunicazione identifica CRGI come una divisione di gestione degli investimenti di Capital Research and Management Company e da entit脿 affiliate che forniscono servizi di investimento con il nome Capital Research Global Investors. La dichiarazione conferma che queste azioni sono state acquisite e sono detenute nell'ordinaria attivit脿 commerciale e non sono state acquistate per modificare o influenzare il controllo dell'emittente.
Capital Research Global Investors (CRGI) informa la titularidad beneficiaria de 50.061.312 acciones ordinarias de Halliburton, que representan el 5,8% de las acciones que se estima est谩n en circulaci贸n. CRGI declara tener poder de voto exclusivo sobre 50.061.245 acciones y poder exclusivo de disposici贸n sobre 50.061.312 acciones. La presentaci贸n identifica a CRGI como una divisi贸n de gesti贸n de inversiones de Capital Research and Management Company y entidades afiliadas que prestan servicios de inversi贸n bajo el nombre Capital Research Global Investors. La declaraci贸n afirma que estas acciones fueron adquiridas y se mantienen en el curso ordinario del negocio y no fueron compradas para cambiar o influir en el control del emisor.
Capital Research Global Investors (CRGI)電� Halliburton 氤错喌欤� 50,061,312欤检棎 雽�頃� 鞁れ鞝� 靻岇湢甓岇潉 氤挫湢頃橁碃 鞛堨溂氅�, 鞚措姅 氚滍枆欤检嫕鞙茧 於旍爼霅橂姅 欤检嫕鞚� 5.8%鞐� 頃措嫻頃滊嫟瓿� 氤搓碃頃╇媹雼�. CRGI電� 50,061,245欤检棎 雽�頃� 雼弲 鞚橁舶甓�鞚�, 50,061,312欤检棎 雽�頃� 雼弲 觳橂秳甓�鞚� 氤挫湢頃橁碃 鞛堧嫟瓿� 氚濏灆雼堧嫟. 鞝滌稖 靹滊電� CRGI毳� Capital Research and Management Company鞚� 韴瀽鞖挫毄 攵�氍� 氚� Capital Research Global Investors霛茧姅 氇呾弓鞙茧 韴瀽 靹滊箘鞀るゼ 鞝滉车頃橂姅 瓿勳棿靷摛搿� 鞁濍硠頃╇媹雼�. 鞚� 歆勳垹鞚� 頃措嫻 欤检嫕霌れ澊 韱奠儊鞝侅澑 鞓侅梾 瓿检爼鞐愳劀 旆摑霅橃柎 氤挫湢霅橁碃 鞛堨溂氅� 氚滍枆鞚胳潣 歆�氚瓣秾 氤�瓴届澊雮� 鞓來枼霠レ潉 頄夓偓頃橁赴 鞙勴暣 旆摑霅� 瓴冹澊 鞎勲嫎鞚� 頇曥澑頃╇媹雼�.
Capital Research Global Investors (CRGI) d茅clare d茅tenir la propri茅t茅 b茅n茅ficiaire de 50 061 312 actions ordinaires de Halliburton, repr茅sentant 5,8% des actions estim茅es en circulation. CRGI indique disposer du pouvoir de vote exclusif sur 50 061 245 actions et du pouvoir exclusif de disposition sur 50 061 312 actions. Le d茅p么t identifie CRGI comme une division de gestion d'investissements de Capital Research and Management Company et des entit茅s affili茅es fournissant des services d'investissement sous le nom Capital Research Global Investors. La d茅claration confirme que ces actions ont 茅t茅 acquises et sont d茅tenues dans le cours normal des affaires et n'ont pas 茅t茅 acquises dans le but de modifier ou d'influencer le contr么le de l'茅metteur.
Capital Research Global Investors (CRGI) meldet wirtschaftliches Eigentum an 50.061.312 Stammaktien von Halliburton, was 5,8% der angenommenen ausstehenden Aktien entspricht. CRGI gibt an, 眉ber 50.061.245 Aktien die ausschlie脽liche Stimmrechtsbefugnis und 眉ber 50.061.312 Aktien die ausschlie脽liche Verf眉gungsbefugnis zu haben. Die Meldung bezeichnet CRGI als Investment-Management-Division von Capital Research and Management Company sowie verbundene Unternehmen, die Anlageleistungen unter dem Namen Capital Research Global Investors erbringen. Die Erkl盲rung best盲tigt, dass diese Aktien im normalen Gesch盲ftsverlauf erworben und gehalten wurden und nicht zum Zweck des Erwerbs oder der Beeinflussung der Kontrolle des Emittenten erworben wurden.
